Real-World Efficacy and Safety of Anlotinib With and Without Immunotherapy in Advanced Non-Small Cell Lung Cancer

AIMS: Combination of anti-angiogenesis therapy and immunotherapy has showed synergistic effects in non-small cell lung cancer (NSCLC). The aim of this retrospective study was to investigate the efficacy and safety of anlotinib with and without immunotherapy in NSCLC. METHODS: Pathologically confirme...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Qi, Qin, Boyu, Xin, Lingli, Yang, Bo, Song, Qi, Wang, Yu, Zhang, Sujie, Hu, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358741/
https://www.ncbi.nlm.nih.gov/pubmed/34395243
http://dx.doi.org/10.3389/fonc.2021.659380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358741/
https://www.ncbi.nlm.nih.gov/pubmed/34395243
http://dx.doi.org/10.3389/fonc.2021.659380

Ejemplares similares